High-dose estrogen treatment in postmenopausal breast cancer patients heavily exposed to endocrine therapy

By Lønning P.E.  

Breast Cancer Research and Treatment, Vol. 67, Iss. 2, 2001-05 ,pp. : 111-116

Springer Publishing Company

Access to resources Recommend Favorite

Efficacy and safety of docetaxel (Taxotere&unknown;) in heavily pretreated advanced breast cancer patients - a national cancer institute treatment referral center trial

By Bonneterre J.   Spielman M.   Guastalla J.-P.   Marty M.   Viens P.   Chollet P.   Roche H.   Fumoleau P.   Mauriac L.   Bourgeois H.   Namer M.   Bergerat J.P.   Misset J.-L.   Trandafir L.   Mahjoubi M.  

European Journal of Cancer, Vol. 35, Iss. 10, 1999-10 ,pp. : 1431-1439

Elsevier

Access to resources Recommend Favorite

Combined endocrine treatment of elderly postmenopausal patients with metastatic breast cancer; A randomized trial of tamoxifen vs. tamoxifen + aminoglutethimide and hydrocortisone and tamoxifen + fluoxymesterone in women above 65 years of age

By Rose C.  

Breast Cancer Research and Treatment, Vol. 61, Iss. 2, 2000-05 ,pp. : 103-110

Springer Publishing Company

Access to resources Recommend Favorite

A phase II study of the combination of endocrine treatment and bortezomib in patients with endocrine-resistant metastatic breast cancer

By                            

Oncology Reports, Vol. 27, Iss. 3, 2012-01 ,pp. : 657-663

Spandidos Publications

Access to resources Recommend Favorite

Four-day infusion of fluorouracil plus vinorelbine as salvage treatment of heavily pretreated metastatic breast cancer

By Zambelli A.   Robustelli della Cuna F.S.   Ponchio L.   Ucci G.   Prada G.A.D.   Robustelli della Cuna G.  

Breast Cancer Research and Treatment, Vol. 61, Iss. 3, 2000-06 ,pp. : 241-247

Springer Publishing Company

Access to resources Recommend Favorite